University Texas Researchers Found Reasons For Blood Clotting Disorder

Researchers find the reason for blood clotting disorder

11:31 AM, 28th August 2013
University of Texas Research News
Dianna Milewicz, Professor, University of Texas.

HOUSTON, US: Research team at The University of Texas has found the variation that was causing the clotting problem in the case it wasn’t hemophilia. Dianna Milewicz, Professor, University of Texas collaborated with Bjorn Dahlback, MD, PhD, from Lund University, Malmo, Sweden, to pinpoint exactly how the variation was causing the clotting problem.

“No surgeon would do elective surgery because they bled too much after surgery. So we collected DNA and plasma from the family and were able to determine that a genetic variant in the Factor V gene was causing production of an abnormal form of the Factor V protein, which we called FV-Short. Factor V is a protein known to be important for the blood to clot. Dr Dahlback is a world expert on Factor V and he was very excited about the research,” said Milewicz.

“I was indeed very excited when hearing about the puzzling results because the knowledge at the time on the role of FV in coagulation could not explain the bleeding disorder. It has been a great privilege to work with Dr Milewicz and her colleagues to decode the unexpected and intriguing mechanisms on how FV-Short caused the bleeding disorder,” said Dahlback.

Genes make proteins that do everything from giving cells shape and structure to helping carry out biological processes. To make the proteins, genes go through a process called alternative splicing that creates coded portions, called exons. The researchers discovered that a mutation in exon 13 of the coagulation FV gene caused a short form of the protein due to changes in the splicing of the exons. That FV-Short protein was unexpectedly found to form a complex in blood with tissue factor pathway inhibitor (TFPI), a protein that inhibits coagulation of the blood. An overabundance of the combined FV-Short/TFPI in the bloodstream keeps the blood from clotting in the affected family members. Other researchers have been looking at ways to inhibit TFPI, which could lead to a treatment for this family’s clotting disorder.

What Milewicz called traditional genetics and “old-fashioned biochemistry” by lead co-author Lisa Vincent, PhD, led to the discovery of the FV-short protein in the blood of affected family members. Dahlback’s work determined how the FV-Short was causing the problems with clotting the blood. Milewicz said studying this family with a rare blood disorder has provided further insight into how the blood clots.

“We knew there was something wrong with these patients’ FV, but proving it required discovering unique properties of FV in coagulation. After many trials and tribulations, our true success is finally being able to provide an answer to the family about their medical issues,” said Vincent.

 

© The University of Texas News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Rockwood completes sale of advanced ceramics business

PRINCETON, US: Rockwood Holdings Inc has completed the sale of CeramTec, its advanced ceramics business to Cinven, a European private equity firm for ...

Read more
Innospec acquires Chemsil, Chemtec; strengthens personal care business

LITTLETON, US: Innospec Inc has acquired Chemsil Silicones Inc and the Chemtec Chemical Co, from its private owners. Chemsil develops and markets sili ...

Read more
BASF opens new research centre in Research Triangle Park, US

LUDWIGSHAFEN, GERMANY/RESEARCH TRIANGLE PARK, US: BASF opened its new research facilities in Research Triangle Park (RTP), North Carolina, US. This $3 ...

Read more
Makhteshim Agan makes two appointments in Europe

TEL-AVIV, ISRAEL/SCHAFFHAUSEN, SWITZERLAND: The Makhteshim Agan Group (MAI), the world leader in branded off-patent crop protection solutions, has two ...

Read more
A Schulman acquires Perrite for $52 million

AKRON, US: A Schulman Inc has purchased the Perrite Group, a thermoplastics manufacturing business with operations in Malaysia, the United Kingdom and ...

Read more
EU approves acquisition of Shell refinery by Nynas in Germany

BRUSSELS, BELGIUM: The European Commission has cleared under the EU Merger Regulation the proposed acquisition of certain refinery assets of Shell Deu ...

Read more